This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Dextrose 20% Injection USP

Starting date:
January 30, 2013
Posting date:
February 18, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-23309

Recalled Products

Dextrose 20% Injection USP

Reason

Lot# 21105JT is recalled as sampling results did not meet the Acceptable Quality Level (AQL) for primary bag leaks during visual inspection.

Depth of distribution

Wholesalers and hospitals in Canada.

Affected products

Dextrose 20% Injection USP

DIN, NPN, DIN-HIM
DIN 00037966
Dosage form

Solution

Strength

200 mg/mL

Lot or serial number

Lot 21105JT

Companies
Recalling Firm
Hospira Healthcare Corporation Suite 600 - 1111 Dr. Frederik Philips Blvd, Saint-Laurent, Quebec H4M 1X6
Marketing Authorization Holder
Hospira Healthcare Corporation Suite 600 - 1111 Dr. Frederik Philips Blvd, Saint-Laurent, Quebec H4M 1X6

Date modified: